Guyi Wang
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Ultrasound in Clinical Applications
Papers in
-
- COVID-19 Clinical Research Studies 7
-
- Asthma and respiratory diseases 4
- Co-authors
- Chenfang Wu (12 shared papers)Guobao Wu (10 shared papers)Yanjun Zhong (9 shared papers)Bo Yu (9 shared papers)Siye Zhang (8 shared papers)Quan Zhang (6 shared papers)Fang Wu (5 shared papers)Jianlei Lv (5 shared papers)
- Journals
- Frontiers in Public Health (2 papers)Frontiers in Medicine (2 papers)Frontiers in Pharmacology (2 papers)Critical Care (1 paper)BMC Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Guyi Wang
32 papers receiving 764 citations
Peers
Comparison fields: 5 of 100
- Infectious Diseases 330
- Critical Care and Intensive Care Medicine 62
- Neurology 108
- Endocrinology, Diabetes and Metabolism 92
- Epidemiology 124
Countries citing papers authored by Guyi Wang
This map shows the geographic impact of Guyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guyi Wang more than expected).
Fields of papers citing papers by Guyi Wang
This network shows the impact of papers produced by Guyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guyi Wang. The network helps show where Guyi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guyi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 190 | |
| 2 | 2020 | 124 | |
| 3 | 2020 | 91 | |
| 4 | 2016 | 49 | |
| 5 | 2013 | 32 | |
| 6 | 2022 | 32 | |
| 7 | 2013 | 30 | |
| 8 | 2021 | 23 | |
| 9 | 2023 | 22 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2011 | 15 | |
| 14 | 2021 | 15 | |
| 15 | 2013 | 14 | |
| 16 | Effects of beta-arrestin 2 on cytokine production of CD4+ T lymphocytes of mice with allergic asthma. | 2011 | 12 |
| 17 | Effects and mechanism of arsenic trioxide on reversing the asthma pathologies including Th17-IL-17 axis in a mouse model. | 2012 | 12 |
| 18 | A PREGNANT WOMAN WITH AVIAN INFLUENZA A (H7N9) VIRUS PNEUMONIA AND ARDS MANAGED WITH EXTRACORPOREAL MEMBRANE OXYGENATION. | 2015 | 10 |
| 19 | 2022 | 10 | |
| 20 | 2024 | 9 |
About Guyi Wang
Guyi Wang is a scholar working on Infectious Diseases, Physiology, Pulmonary and Respiratory Medicine, Immunology and Social Psychology, having authored 32 papers that have together received 788 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Asthma and respiratory diseases (4 papers), Music Therapy and Health (3 papers), IL-33, ST2, and ILC Pathways (2 papers), RNA modifications and cancer (2 papers), Long-Term Effects of COVID-19 (2 papers), Neuroscience and Music Perception (2 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Infectious Diseases (330 citations), Critical Care and Intensive Care Medicine (62 citations), Neurology (108 citations), Endocrinology, Diabetes and Metabolism (92 citations) and Epidemiology (124 citations). Guyi Wang has collaborated with scholars based in China and United States. Frequent co-authors include Chenfang Wu, Guobao Wu, Yanjun Zhong, Bo Yu, Siye Zhang, Quan Zhang, Fang Wu, Jianlei Lv, Haiyun Dong and Xudong Xiang. Their work appears in journals such as Frontiers in Public Health, Frontiers in Medicine, Frontiers in Pharmacology, Critical Care and BMC Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.